# Spironolactone and Perioperative Atrial Fibrillation Occurrence in Cardiac Surgery Patients.

Study · id `cardio:ct-nct03551548` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03551548](<https://clinicaltrials.gov/study/NCT03551548>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03551548

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 1500 participants.

## Technical summary

Registry record NCT03551548. Randomized; quadruple masking; primary purpose treatment. Start 2019-02-26 (actual); primary completion 2021-07 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 1500 participants (planned count; ClinicalTrials.gov record NCT03551548, source copy `cardio:ctgov-nct03551548-2019-03-05`, retrieved 2026-10-26)
- Started: 2019-02-26 (actual) (ClinicalTrials.gov record NCT03551548, source copy `cardio:ctgov-nct03551548-2019-03-05`, retrieved 2026-10-26)
- Primary completion: 2021-07 (anticipated) (ClinicalTrials.gov record NCT03551548, source copy `cardio:ctgov-nct03551548-2019-03-05`, retrieved 2026-10-26)
- Completion: 2021-09 (anticipated) (ClinicalTrials.gov record NCT03551548, source copy `cardio:ctgov-nct03551548-2019-03-05`, retrieved 2026-10-26)
- Countries: France (ClinicalTrials.gov record NCT03551548, source copy `cardio:ctgov-nct03551548-2019-03-05`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03551548-2019-03-05`, retrieved 2026-10-26)

## The registry's words

- Brief title: Spironolactone and Perioperative Atrial Fibrillation Occurrence in Cardiac Surgery Patients.
- Acronym: ALDOCURE
- Condition: Cardiac Surgery
- Condition: Atrial Fibrillation
- Condition: Aldosterone Blockade
- Intervention (Drug): Spironolactone 25mg
- Intervention (Drug): Placebo oral capsule
- Lead sponsor: University Hospital, Caen
- Lead sponsor class: OTHER
- Collaborator: Ministry of Health, France
- Collaborator class: OTHER\_GOV

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry lists this organization as the lead sponsor: University Hospital, Caen (`cardio:org-university-hospital-caen`)
- Registry lists this organization as a collaborator: Ministry of Health, France (`cardio:org-ministry-of-health-france`)

## Provenance

Content hash: 7a2ba71d6eab20d19f2deef16c9f9997615985396435666c59829f468d6c69a6
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
